Radiotherapy for asymptomatic brain metastasis in epidermal growth factor receptor mutant non-small cell lung cancer without prior tyrosine kinase inhibitors treatment: a retrospective clinical study
暂无分享,去创建一个
Mengzhong Liu | F. Wang | Likun Chen | Shiliang Liu | P. Cai | Ying-ying Liang | B. Qiu | Hui Liu | Songran Liu | Li Zhang | Z. Chen
[1] G. Bootsma,et al. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases , 2014, Acta oncologica.
[2] Andreas Rimner,et al. Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma. , 2014, International journal of radiation oncology, biology, physics.
[3] Mahmoud M El Gantery,et al. Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both , 2014, Radiation oncology.
[4] J. Shao,et al. High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR , 2013, Journal of Translational Medicine.
[5] J. Shao,et al. High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR , 2013, Journal of Translational Medicine.
[6] L. Ting,et al. EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases , 2012, Radiation oncology.
[7] Dae-Ho Lee,et al. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. , 2012, Lung Cancer.
[8] Takashi Ogura,et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features. , 2012, Lung cancer.
[9] F. Kousar,et al. Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols. , 2012, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[10] Z. Li,et al. The retrospective analysis of the frequency of EGFR mutations and the efficacy of gefitinib in NSCLC patients with brain metastasis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] L. Sequist,et al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. , 2010, Neuro-oncology.
[12] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[13] T. Mok,et al. Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis , 2009, Journal of cellular and molecular medicine.
[14] Sang-We Kim,et al. Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis. , 2009, Lung cancer.
[15] J. Shih,et al. Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] E. Stathopoulos,et al. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC , 2008, British Journal of Cancer.
[17] Yih-Leong Chang,et al. Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response , 2008, Clinical Cancer Research.
[18] Tongtong Zhang,et al. Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain. , 2007, Lung cancer.
[19] T. Mok,et al. Epidermal Growth Factor Receptor Mutations and Their Correlation with Gefitinib Therapy in Patients with Non-small Cell Lung Cancer: A Meta-Analysis Based on Updated Individual Patient Data from Six Medical Centers in Mainland China , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] J. Yokota,et al. Frequent EGFR mutations in brain metastases of lung adenocarcinoma , 2006, International journal of cancer.
[21] P. Brown,et al. Whole-brain radiotherapy in the management of brain metastasis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Mehta,et al. Current management of brain metastases, with a focus on systemic options. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Kris,et al. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib , 2005, Cancer.
[24] Shih-Feng Tsai,et al. High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan , 2004, Clinical Cancer Research.
[25] Patricia L. Harris,et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.
[26] F. Cappuzzo,et al. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC). , 2003, Lung cancer.
[27] Allan H Friedman,et al. Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa). , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[29] L. Collette,et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] H. Minn,et al. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. , 1998, Annals of medicine.